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ABSTRACT 
The interaction of naringin with bovine serum 
albumin has been performed using fluores-
cence, circular dichroism and fourier transform 
infrared spectroscopy in 20 mM phosphate 
buffer of pH 7.0 as well as molecular docking 
studies. The changes in enthalpy (ΔH°) and en-
tropy (ΔS°) of the interaction were found to be 
+18.73 kJ/mol and +143.64 J mol-1 K-1 respec-
tively, indicating that the interaction of naringin 
with bovine serum albumin occurred mainly 
through hydrophobic interactions. Negative 
values of free energy change (ΔG°) at different 
temperatures point toward the spontaneity of 
the interaction. Circular dichroism studies re-
veal that the helical content of bovine serum 
albumin decreased after interaction with nar-
ingin. According to the Förster non-radiative 
energy transfer theory the distance between Trp 
213 residue and naringin was found to be 3.25 
nm. Displacement studies suggest that naringin 
binds to site 1 (subdomain IIA) of bovine serum 
albumin (BSA) which was also substantiated by 
molecular docking studies. 
Keywords: Naringin; Bovine Serum Albumin; 
Fluorescence; Binding; Warfarin; Docking 
1. INTRODUCTION 
Plant sources are abundant in the common poly-
phenolic compounds known as flavonoids that are 
known to possess various types of pharmacological 
effects including antioxidant, anti-microbial, anti-in-
flammatory, anti-allergic and anti-cancer activity [1-7]. 
The importance of the antioxidant activity of these 
compounds lies in their ability to scavenge free radi-
cals [8] that are responsible for DNA damage. Nar-
ingin (Figure 1), a major bioflavonoid in grapefruit 
has been shown to reduce radiation-induced damage to 
DNA [9]. Naringin also acts as the inhibitor of VEGF 
release, which causes angiogenesis [10] and has been 
proven to be effective against ethanol injury in rats 
[11]. The chemopreventive role of naringin against 
protoxicants, its action as anti-atherogenic agents in 
rabbits and its ability to significantly reduce the level 
of total cholesterol have also been established [12-14]. 
Apart from being able to provide protection against the 
autophagy-inhibitory effect of okadaic acid, it also 
possesses anti-apoptotic properties [15,16]. The oral 
bioavailability of quinine in rats has been shown to 
increase after pretreatment with naringin [17]. 
Serum albumins are the most abundant carrier pro-
teins of blood plasma that promote the transportation 
and disposition of exogenous and endogenous materi-
als in blood. They are able to bind with different bio-
logically active compounds (drugs, fatty acids, steroids, 
dyes etc) in the body [18-20]. The structure of BSA is 
homologous to HSA (human serum albumin) and con-
sists of three linearly arranged domains (I-III) that are 
composed of two subdomains (A and B) [21-23]. There 
are two tryptophans (Trp 134 and Trp 213) in BSA, of 
which Trp 134 is located on the surface of the mole-
cule and Trp 213 resides in the hydrophobic pocket 
similar to Trp 214 in HSA [24,25]. Like other serum 
albumins bovine serum albumin (BSA) possesses a 
wide range of physiological functions associated with 
the binding, transport and distribution of biologically 
active compounds. The binding affinity to serum al-
bumins also influences the effectiveness of the drugs at 
the active site. Thus the study of the interactions of 
small drug molecules with serum albumins provides a 
good insight into an understanding of the recognition 
pattern under physiological conditions [26]. In this 
regard, BSA is extensively used because of its intrinsic 
structural similarity with HSA [27-30]. 
Analyses of the interactions of small ligands with 
biomacromolecules include the use of optical spec-
troscopy as an important tool [31-35]. Studies of the 
interaction of antioxidant flavonoids with serum albu-
mins are of pharmaceutical importance. The binding 
parameters derived from the spectroscopic methods 
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Figure 1. Structure of naringin. 
 
play a major role in pharmacokinetics [36,37]. To this 
effect, the interactions of hesperidin and naringin with 
the serum albumins have been preliminary reported upon 
by fluorescence and absorption spectroscopy as this re-
port was in preparation [38,39]. Our studies have further 
investigated the interactions between naringin and BSA 
by fluorescence, circular dichroism and Fourier Trans-
form infrared spectroscopy. Molecular displacement 
studies to identify the site of binding have also been 
conducted along with synchronous fluorescence experi-
ments. Thermodynamic parameters determined from 
measurements at four different temperatures, indicated 
that hydrophobic interactions play an important role in 
the association. These observations were further sub-
stantiated by the FTIR studies providing additional in-
sight into the mode of binding. Finally, protein ligand 
docking studies have been conducted to identify the 
residues likely to be involved in the binding. 
2. MATERIALS AND METHODS 
2.1. Materials 
BSA and the other analytical grade reagents were pur-
chased from SRL (India). Naringin, warfarin, ibuprofen 
and 8-anilino-1-naphthalene sulfonic acid (ANS) were 
obtained from Sigma (USA). Stock solutions of naringin, 
warfarin and ibuprofen were prepared in doubled distilled 
water. BSA was dissolved in 20 mM phosphate buffer of 
pH 7.0. The concentrations were measured spectropho-
tometrically (Shimadzu UVPC 2450) using their molar 
extinction coefficient values: ε280 (BSA) = 43800 M-1 cm-1 
[40], ε308 (warfarin) = 12500 M-1 cm-1 [41], ε280 (naringin) 
= 17400 M-1 cm-1 [42], ε222 (ibuprofen) = 12700 M-1 cm-1 
[43]. All the experiments were carried out in 20 mM 
phosphate buffer of pH 7.0. 
2.2. Fluorescence Spectroscopy 
2.2.1. Fluorescence Quenching Studies 
All the fluorometric experiments were carried out in a 
Horiba Jobin Yvon spectrofluorometer (Fluoromax 4) 
using a 1 cm quartz cell. A 3.0 mL solution of 2 μM BSA 
was titrated with successive addition of naringin (0 to 36 
μM) at four different temperatures (293, 299, 305 and 
311 K). The excitation wavelength was 295 nm and the 
emission spectra were recorded from 305 to 500 nm. The 
intensities of emission maxima were used for the calcu-
lation of binding constants, occupation of binding sites 
and thermodynamic parameters. 
The Stern-Volmer equation can be used to describe the 
fluorescence quenching process [44]. 
][1][10 QKQK
F
F
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where τ0 (5 ns [45]) is the lifetime of the fluorophore in 
absence of quencher and kq is the bimolecular quenching 
constant. KSV is the Stern-Volmer quenching constant 
and [Q] is the quencher concentration. KSV were obtained 
by plotting F0/F versus [Q] and if KSV is much larger 
than 2×1010 M-1 s-1, it can be concluded that the quench-
ing is static in nature. The modified Stern-Volmer equa-
tion was also taken to analyze the fluorescence quench-
ing method using the equation given below: 
Aaa KfQfF
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where ΔF = F0 – F; F0 and F are the relative fluores-
cence intensities in absence and presence of the 
quencher, respectively, fa the fraction of fluorophore 
accessible to the quencher, [Q] the concentration of the 
quencher and KA is the Modified Stern-Volmer quench-
ing constant. The plot of F0 /ΔF versus 1/[Q] yields 1/fa 
as the intercept, and 1/KA fa as the slope. From the inter-
cept and slope the values for fa and KA can be obtained. 
The number of binding sites and the binding constant 
of the interaction of naringin with BSA can be obtained 
from the following equation [46]. 
  bKQn
F
F logloglog              (3) 
where ΔF = F0 – F, F0 and F are the fluorescence inten-
sities of protein in presence and presence of quencher, n 
is the number of binding sites and Kb the equilibrium 
binding constant. 
The mode of interaction of naringin with BSA was 
ascertained from the change in enthalpy (ΔH°) and en-
tropy (ΔS°) [47]. This can be done by using the van’t 
Hoff equation Eq.4: 
R
S
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where Kb is the equilibrium binding constant at the cor-
responding temperature and R the universal gas constant. 
The free energy change (ΔG°) associated with the inter-
action of naringin with BSA can be calculated from the 
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values of ΔH° and ΔS° using the following equation: 
 STHG                 (5) 
2.2.2. Synchronous Fluorescence Quenching of 
BSA by Naringin 
Synchronous fluorescence spectra of BSA (2 μΜ) 
were recorded with increasing concentrations of naringin 
(0 to 14 μΜ), by setting Δλ = 60 nm and Δλ = 15 nm for 
tryptophan and tyrosine residues respectively [48]. 
2.2.3. 8-Anilino-1-Naphthalene Sulfonic acid 
(ANS) Displacement Study 
2 μΜ BSA was saturated with 6 μΜ ANS [49] in 20 
mM phosphate buffer of pH 7.0 and incubated for 1 hour. 
The mixture was then titrated successively with addition 
of naringin (0 to 21 μΜ). The concentration of ANS was 
determined spectrophotometrically using its molar ab-
sorption coefficient of 4950 M-1 cm-1 at 350 nm [50]. 
The excitation wavelength for ANS-bound BSA was set 
at 375 nm and emission observed at 474 nm. 
2.2.4. Warfarin and Ibuprofen Displacement 
Studies 
For the displacement study of warfarin bound to BSA, 
a 3 mL solution was prepared containing 2 μM of war-
farin and BSA and kept for 1 hour. Titrations were per-
formed with increasing concentrations of naringin (0 to 
40 μM) on excitation at 308 nm. Another set containing 
1 μM ibuprofen and 2 μM BSA was prepared to check 
the displacement of ibuprofen bound BSA. After a 1 
hour incubation period titration was done by successive 
addition of naringin (0 to 21 μM) using an excitation 
wavelength of 265 nm. 
2.3. Fluorescence Resonance Energy Transfer 
The rate of energy transfer depends on the extent of 
overlap between the emission spectrum of the donor 
(protein) and the absorption spectrum of the acceptor 
(ligand) and the relative orientations of the transition 
dipoles. In accordance to Förster’s theory, the efficiency 
of energy transfer, E, is estimated using the following 
Eq.6 [51]. 
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where F0 and F are the fluorescence intensities of the 
BSA in the absence and presence of naringin. The dis-
tance from the ligand to the fluorophore of the protein is 
r and R0 is the Förster distance at which 50% of the ex-
citation energy is transferred to the acceptor. The value 
of R0 can be obtained from Eq.7. 
)]([(1078.9 42360  JQnR D           (7) 
where QD is the quantum yield of the donor in absence 
of acceptor, n the refractive index of the medium, J(λ) is 
the overlap integral of the emission spectra of donor and 
absorption spectra of the acceptor and κ2 is the relative 
orientations in space of the transition dipoles of the do-
nor and acceptor. The overlap integral J(λ) is calculated 
from the following equation: 

 

dF
dF
J
)(
)()(
)(
4
             (8) 
where F(λ) is the corrected fluorescence intensity of the 
donor in the range of λ to λ + Δλ with the total intensity 
normalized to one with the quantity F(λ) dimensionless, ε(λ) 
is the molar extinction coefficient of the acceptor at λ nm. 
2.4. Circular Dichroism Measurements 
All CD experiments were carried out on a Jasco-810 
automatic spectrophotometer using a 0.1 cm cell length 
at room temperature. The concentration of BSA used for 
the CD study was 9 μM in 20 mM phosphate buffer of 
pH 7.0. Five sets of solutions were prepared containing 
BSA and naringin in the following proportions 1:0, 1:2, 
1:4, 1:6 and 1:8 respectively. Spectra were recorded in 
the range of 190 to 240 nm with a scan rate of 50 
nm/min and the response time was fixed at 4 s during the 
measurements. The mean residual ellipticity (MRE) in 
deg cm2 dmol-1 can be estimated using Eq.9 [52]. 
10
deg)(
 lnC
mobservedCDMRE
p
            (9) 
where n is the number of residues in the protein, Cp is 
the molar concentration of the protein and l is the path 
length. From the MRE values at 208 nm we can calculate 
the α-helical content of free and complexed BSA using 
the following Eq.10 [52,53]. 
100
400033000
)4000((%) 208 
 MREhelix      (10) 
Where MRE208 is to the observed MRE values, 33000 
and 4000 are the MRE values of a pure α-helix and of 
the β-form and random coil conformation at 208 nm 
respectively. 
2.5. FT-IR Spectroscopic Measurements 
FT-IR measurements were carried out on Nexus-870 
FT-IR spectrometer equipped with a DTGS detector, a 
KBr beam splitter, Zn-Se attenuated total reflection 
(ATR) accessory at room temperature. A 256-scan inter- 
ferogram with 4 cm-1 resolution were used to collect the 
spectra. Eighteen milligrams of BSA was dissolved in 20 
mM phosphate buffer of pH 7.0 giving a concentration 
of 0.27 mM. Three additional sets of samples were pre-
pared keeping the ratio of BSA and naringin as 1:1, 1:2 
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Table 1. KSV and Kq values for the binding interaction of 
naringin with BSA in 20 mM phosphate buffer of pH 7.0. 
Temperatures KSV in M-1 Kq in M-1 s-1 
293 K 1.682 × 104 3.364 × 1013 
299 K 1.725 × 104 3.451 × 1013 
305 K 1.754 × 104 3.508 × 1013 
311 K 1.852 × 104 3.704 × 1013 
 
and 1:3. The background was corrected before scanning 
the samples and the buffer spectrum collected. Blank 
spectra were taken to subtract them from the BSA-nar-
ingin combined spectra. The secondary structural analy-
ses were performed according to Byler and Susi [54]. 
2.6. Molecular Docking Study 
The structure of BSA is unavailable in the Protein 
Data Bank [55], so a homology model was used for the 
docking with naringin. The BSA sequence [Swissport 
sequence ALBU_BOVIN (P02769)] has 75% similarity 
with HSA. The model structure was obtained from 
SAM_T06 server [56-60]. The energy minimized struc-
ture of naringin was obtained by Sybyl 6.92 (Tripos Inc., 
St. Louis, USA) using Amber 7.0 force field and 
Gasteiger-Huckel charges. FlexX in the Sybyl suite car-
ried out the docking of naringin with BSA. PyMol was 
used to visualize the docked conformation [61]. The 
accessible surface area (ASA) of free and complexed 
BSA was calculated with the help of NACCESS [62]. 
The change in ASA on complex formation for a specific 
residue n was calculated using ΔASAn = ASAn (free BSA) 
– ASAn (naringin-BSA). If any residue lost more than 10 
Å2 on complex formation it was assumed that it partici-
pated in the association. 
3. RESULTS AND DISCUSSION 
3.1. Fluorescence Spectroscopy 
3.1.1. Fluorescence Quenching Mechanism 
and Fractional Accessibility of the 
Quencher 
The fluorescence emission spectra of BSA in absence 
and presence of naringin is given in Figure 2. BSA ex-
hibits a strong emission at 347 nm on excitation at 295 
nm with naringin being non-fluorescent under the ex-
perimental conditions. The fluorescence intensity of 
BSA decreases with successive addition of naringin in 
20 mM phosphate buffer of pH 7 indicating that naringin 
can quench the intrinsic fluorescence of BSA. Generally, 
fluorescence quenching occurs through both dynamic 
(collisional) and static means. In the latter there is com-
plex formation between the protein and the quencher. 
Most commonly the processes are distinguished by their 
dependence on temperature. The maximum value possi-
ble for the collision quenching constant of the biomac-
romolecule is 2 × 1010 M-1 s-1 in aqueous medium. The 
interaction of naringin with BSA involves static quench-
ing, as the KSV values at the four different temperatures 
studied are greater than this value (Table 1). The Stern- 
Volmer plots at four different temperatures are shown in 
supplementary, Figure S1. The difference spectra from a 
UV-Vis study were also used to analyze the quenching 
mechanism of the interaction. For dynamic quenching, it 
is necessary that the UV-Vis spectrum of BSA can be 
superimposed with the difference spectrum of BSA- 
Naringin minus naringin [63]. However, in the present 
study this was not observed which ruled out any dy-
namic quenching process (Supplementary Figure S2). 
From the intercept and slope the values for fa and KA 
can be obtained (Supplementary Figure S3(a)). The val-
ues of fa of Trp 213 were calculated at four different 
temperatures using Eq.2. The average value of fa was 
0.81 ± 0.09 indicating that naringin could easily bind to 
the hydrophobic pocket of site 1 of subdomain IIA and 
that ~80% of the total fluorescence of Trp 213 is acces-
sible to the quencher. 
3.1.2. Binding Constant and Mode of Binding 
from Thermodynamic Parameters 
The values of Kb have been calculated at each tempera-
ture using Eq.3 with the corresponding plots in supple-
mentary Figure S3(b). The binding constants are found to 
be in the order of 104 M-1 as reported earlier [39]. It has 
been observed that there is an increase in the binding con-
stant with rise in temperature. The binding constant and 
the number of binding sites are listed in the Table 2. 
The average value of ΔG° obtained is –24.65 ± 1.11 
kJ/mol. The values of change in enthalpy (ΔH°) and en-
tropy (ΔS°) for the interaction were found to be + 18.73 
kJ/mol and +143.64 J mol-1 K-1 respectively (Supple-
mentary, Figure S4). The mode of interaction of small 
ligands with the biomacromolecules based on the signs 
of the thermodynamic parameters obtained has been 
characterized by Ross and Subramanian [47]. The posi-
tive sign for both ΔH° and ΔS° indicates a predomi-
nantly hydrophobic interaction between naringin and 
BSA. This is also supported by the spectral blue shift 
observed in the emission spectra of BSA in presence of 
naringin (Figure 2). The values indicate that the major 
contribution to ΔG° arises from the change in entropy 
rather than the change in enthalpy as shown in the bar 
diagram (Figure 3). Hence we can conclude that the 
binding process is entropy driven process. 
3.1.3. Synchronous Fluorescence Analysis 
Synchronous fluorescence studies were conducted to 
provide information about the molecular environment of       
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Table 2. Binding and thermodynamic parameters for the complexation of naringin with BSA at different temperatures. 
Temp. 10-4 × Kb (M-1) n 10-4 × KA (M-1) fa 
G° 
(kJ mol-1) 
H° 
(kJ mol-1) 
S° 
(J mol-1 K-1) 
293 K 1.473 ± 0.0247 (R2 = 0.9947) 1.041 
1.703 ± 0.4217 
(R2 = 0.9916) 0.942 –23.36 
299 K 1.751 ± 0.0257 (R2 = 0.9943) 0.994 
2.217 ± 0.2827 
(R2 = 0.9954) 0.799 –24.22 
305 K 1.862 ± 0.0465 (R2 = 0.9785) 0.979 
2.369 ± 0.4632 
(R2 = 0.9871) 0.769 –25.08 
311 K 2.138 ± 0.0458 (R2 = 0.9775) 0.943 
2.845 ± 0.3471 
(R2 = 0.9903) 0.737 –25.94 
+18.73 +143.64 
 
 
Figure 2. Fluorescence emission spectra of BSA 
(2 μΜ) in absence (top line) and presence (bottom 
lines) of naringin (0 to 36 μΜ) at 299 K in 20 mM 
phosphate buffer of pH 7.0; λex = 295 nm. Arrows 
indicate the progress of titration. 
 
 
Figure 3. The bar diagram for interaction of nar-
ingin (0 to 36 μΜ) with BSA (2 μΜ) in 20 mM 
phosphate buffer of pH 7.0. λex = 295 nm. 
 
the chromophores present in the protein [64]. The syn-
chronous fluorescence intensity of tryptophan residues 
decreased after addition of naringin with an associated 
blue shift from 347 to 345 nm (Supplementary Figure 
S5a). In accordance with the thermodynamic parameters, 
the blue shift in the synchronous emission spectra clearly 
indicates that naringin binds to the hydrophobic cavity of 
BSA where Trp 213 is located. On the other hand, the 
fluorescence intensity of tyrosine decreases regularly 
with increasing concentration of naringin, but no sig-
nificant change in λem was observed (Supplementary 
Figure S5(b)). This observation suggests that the mi-
croenvironment around tyrosine remains unaffected after 
the addition of naringin. 
3.1.4. Analysis of site Marker Displacement Studies 
It is known that ANS, a fluorescent hydrophobic 
probe binds to the non-polar region of proteins, which 
corresponds to site 1 comprising subdomains IIA and 
IIIA of HSA and BSA [38,65]. The displacement of ANS 
bound to BSA after the addition of naringin (Supple-
mentary Figure S6) indicates that naringin does bind to 
site 1 of the protein [66]. This displacement also indi-
cates the involvement of a hydrophobic interaction in the 
complexation process that has also been found from the 
thermodynamic parameters. 
The decrease in fluorescence intensity observed in 
case of bound warfarin to BSA (Supplementary Figure 
S7) supports the observation that naringin binding com-
petes for the same site in BSA (subdomain IIA and IIIA). 
An additional experiment with ibuprofen bound to BSA 
was also performed (Supplementary Figure S8) to check 
whether naringin binds to site 2 (subdomain IIIA). The 
binding constants of the interaction of naringin with 
BSA were calculated in presence of warfarin and ibu-
profen according to Eq.3 at 299 K (Supplementary Fig-
ure S9). 
The binding constant for the complex formation at 
this temperature is 1.75 x 104 M-1 (the mean ±sd being 
1.80 ± 0.28 x 104 M-1). In case of warfarin and ibupro-
fen the values were found to be 1.49 × 104 and 2.29 × 
104 M-1. This implies that the addition of naringin to 
warfarin bound protein was able to disrupt the binding 
as there is a decrease in the binding constant. In case of 
ibuprofen bound BSA the binding constant does not 
decrease. These results suggested that naringin binds 
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preferentially to site 1 (subdomain IIA) where warfarin 
binds. This result is also supported by the binding of 
naringin to HSA where it is also found to bind to the 
same site [36]. Docking results (below) also support this 
observation. 
3.2. Energy Transfer from Donor to Acceptor 
The overlap of the absorption spectrum of naringin 
with the fluorescence emission spectrum of BSA is 
shown in Figure 4. The values of κ2, N and QD are 2/3, 
1.336 and 0.15 respectively [67]. The value of J(λ) was 
estimated from Eq.8 with the help of Origin 6.0, from 
305 to 450 nm and was found to be 6.1 × 10-15 M-1 
cm3. 
Using Eq.7 R0 was calculated to be 2.32 nm. The 
value of r from Eq.6 using E = 0.117 was 3.25 nm. 
The donor-to-acceptor distance r < 7 nm and 0.5R0 < r 
< 2 R0 [44], indicated that the energy transfer from the 
Trp 213 residue to naringin occurred with high pro-
pensity. This also explains the quenching of tryptophan 
fluorescence. 
3.3. Circular Dichroism 
The CD spectrum of BSA exhibits two negative bands 
in the ultraviolet region at 208 (π→π* transition) and 222 
nm (n→π* transition) as shown in Figure 5 and this is 
characteristic of the α-helical structure of a protein. The 
interaction between naringin and BSA caused a slight 
decrease in band intensity at all wavelengths of the far 
UV CD without any significant shift in the peak position. 
The α-helical content of free BSA was 65%. The 
α-helical content of BSA decreased to 63, 62, 61 and 
59% on 1:2, 1:4, 1:6 and 1:8 binding with naringin. This 
can be treated as a minor conformational change in pro-
tein structure in presence of the external ligand. In pres- 
 
 
Figure 4. Spectral overlap between fluorescence emis-
sion spectrum of BSA (solid line) with the absorption 
spectrum of naringin (dotted line) in 20 mM phosphate 
buffer of pH 7.0. [naringin]/[BSA] = 1:1, λex = 295 nm; λem = 347 nm. 
 
Figure 5. CD spectra of free BSA (dotted line) and com-
plexed (solid lines) with naringin ([BSA]:[naringin] ra-
tios are 1:2, 1:4, 1:6 and 1:8) in 20 mM phosphate buffer 
of pH 7.0. 
ence of naringin the α-helical content of HSA is also 
found to decrease [38]. 
3.4. FT-IR Analysis 
The secondary structure of proteins correspond to 
1650-1654 cm-1 (amide I, due to C=O stretching) and 
1548-1560 cm-1 (amide II, due to C-N stretching coupled 
with N-H bending) [54]. The FT-IR spectra of BSA 
(Figure 6(a)) show the effect on the secondary structure 
of BSA due to complexation. The amide I of free BSA 
has shifted from 1649 cm-1 to 1651 cm-1. The peaks near 
1552 cm-1 shifted to 1549 cm-1 showing the effect on 
binding of naringin to BSA on the amide II region 
[68,69]. Free BSA shows peaks at 1456 cm-1, 1438 cm-1 
and 1423 cm-1 that arise due to antisymmetric angle 
bending of CH3 groups and angle bending of CH2 of the 
side chains [67]. After complexation with naringin the 
peaks shift to some extent (Figure 6(b)) indicating the 
involvement of a hydrophobic interaction in the binding 
of naringin to BSA. The difference spectra (Supplemen-
tary, Figure S11) show positive bands at 1618, 1635, 
and 1648 cm-1 (amide I) and 1520, 1552 and 1568 cm-1 
(amide II) for a 1:1 complex. Negative peaks arise in the 
difference spectra at 1:2 and 1:3 ratios indicating the 
presence of H-bonding of naringin with BSA [54,68]. It 
was also observed that the secondary structure of BSA 
was perturbed in presence of naringin. The α-helical 
content of BSA decreases from 66 to 47% as observed in 
the CD studies. The difference in values for the % con-
tent arise due to the calculations arising from differences 
in electronic transitions and vibrational transitions which 
are the observed responses in case of circular dichroism 
and infrared spectra respectively. The % α-helical con-
tent was calculated from the deconvoluted spectra of 
BSA and BSA-naringin complex (Supplementary, Fig-
ure S10). 
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(a) 
 
 
(b) 
Figure 6. (a) FT-IR spectra of BSA (dotted line) and BSA 
bound with naringin (solid lines) in the region 1800-1400 
cm-1 and (b) in the region 1460-1400 cm-1 in 20 mM phos-
phate buffer of pH 7.0. The contribution of naringin was 
subtracted from the BSA-Naringin complexes. 
3.5. Docking Results 
The docked conformation of naringin with BSA is 
given in Figure 7. From the docking study it is clear 
that the drug naringin binds to hydrophobic site 1 
(subdomain IIA) where Trp 213 residue is located. 
This also supports the hydrophobic character of bind-
ing of naringin with BSA, which is corroborated by the 
thermodynamics of the interaction. Fluorescence stud-
ies that show a blue shift on complex formation also 
support the hydrophobic association. Changes in ASA 
of specific residues involved in the interaction are 
given in Table 3. There is a possible hydrogen bond 
interaction between 4-C=O of naringin with Arg 198 
and Arg 217; 23-OH and Asp 450; 25-OH and –NH of 
Lys 187. This interaction decreases the hydrophilicity 
and increases the hydrophobicity that results in the 
stabilization of the BSA- naringin complex. A similar 
observation has also been reported in case of the in-
teraction of naringin with HSA [36]. 
 
Figure 7. The docking pose of naringin with BSA. 
 
Table 3. The distances (Ǻ) between naringin and BSA and 
change in accessible surface area (ΔASA) of residues of BSA 
after interaction with naringin. 
 
4. CONCLUSION 
The binding of naringin with BSA under physiological 
conditions has been presented by fluorescence spectros 
copy in combination with CD, FTIR and molecular 
docking studies. We observe that naringin binds to the 
hydrophobic site 1 (subdomain IIA) of BSA as con-
firmed from both experimental and docking results. The 
binding constants were obtained in order of 104. The 
distance between Trp 213 and naringin was 3.25 nm, 
which predicts that there is a possibility of energy trans-
fer from donor to acceptor. The negative value of ΔG° 
implies the spontaneity of the complexation. According 
to the docking studies naringin is within hydrogen 
bonding distance of Trp 213. The study of the interac-
tions of naturally occurring polyphenols with serum al-
bumins is essential for the understanding of how the 
molecules may be modified to target specific diseases, 
since the polyphenols are widely known to have a mul-
titude of pharmacological activities. 
Residues Distance (Å) ΔASA (Å2) 
Lys 187 Nη1 4.35 [25-O] 41.67 
Arg 194 Nη1 3.58 [5-O] 77.25 
Arg 198 Nη1 
Nη2 
2.95 [4-C=O] 
4.40 [4-C=O] 12.59 
Trp 213 (N) 2.81 [4΄-O] 25.34 
Arg 217 Nη1 
Nη2 
2.86 [4-C=O] 
4.01 [4-C=O] 32.21 
Glu 291  65.64 
Glu 449 Oδ1 
Oδ2 
2.92 [4΄-O] 
4.63 [4΄-O] 12.32 
Asp 450 C=O 4.38 [23-OH] 66.98 
Tyr 451 - 16.34 
Ser 453 - 13.94 
Leu 454 - 20.91 
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Supplementary Information 
 
A spectroscopic study of the interaction of the antioxi- 
dant naringin with bovine serum albumin 
 
Figure S1. Stern-Volmer plots for the interaction of Nringin with 
BSA at different temperatures in 20 mM phosphate buffer of pH 
7.0; (♦) 293 K, (▬) 299 K (▲) 305 K (■) 311 K, λex = 295 nm. 
 
 
Figure S2. The UV-Vis spectra of BSA, naringin and the dif-
ference spectra of (BSA-Naringin) minus naringin system. 
[BSA] = [Naringin] = 25 μM. 
 
 
(a) 
 
 
(b) 
Figure S3. (a) Modified Stern-Volmer plot of BSA (2 
μΜ) with increasing concentration of naringin (0 to 
36 μΜ) and (b) Double logarithm plot for the inter-
action of naringin (0 to 36 μΜ) with BSA (2 μΜ). (♦) 
293 K, (▬) 299 K (▲) 305 K (■) 311 K. λex = 295 
nm. 
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Figure S4. The van’t Hoff plot and (b) the bar diagram 
for interaction of naringin (0 to 36 μΜ) with BSA (2 μΜ) 
in 20 mM phosphate buffer of pH 7.0. λex = 295 nm. 
 
 
(a) 
 
(b) 
Figure S5. Synchronous fluorescence spectra of BSA when (a) 
∆λ = 60 nm and (b) ∆λ = 15 nm in absence (top line) and pres-
ence (bottom lines) of naringin (0 to 14 μΜ) in 20 mM phos-
phate buffer of pH 7.0 at 299 K. Arrows indicate the progress 
of titration. 
 
Figure S6. Displacement of bound ANS from BSA-ANS 
complex by naringin (0 to 21 μΜ); [BSA] = 2 μΜ, [ANS] = 6 
μΜ; λex:375 nm. Arrows indicate the progress of titration. 
 
 
Figure S7. Displacement of bound warfarin from BSA- 
warfarin complex by naringin (0 to 40 μM); [BSA] = [war-
farin] = 2 μΜ; λex: 308 nm. Arrows indicate the progress of 
titration. 
 
 
Figure S8. Displacement of bound ibuprofen from BSA- 
ibuprofen complex by naringin (0 to 21 μΜ); [BSA] = 2 
μΜ; [ibuprofen] = 1 μΜ; λex: 265 nm. Arrows indicate the 
progress of titration. 
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Figure S9. The effect of site marker probe on the binding of naringin with 
BSA in 20 mM phosphate buffer of pH 7.0 at 299 K. (▲) BSA-ibuprofen 
(♦) BSA-warfarin complex; λex: 265 and 308 nm respectively. 
 
 
Figure S10. Curve-fitted amide I (1700-1600 cm-1) regions of free BSA and BSA-naringin complexes (molar 
ratios 1:1, 1:2 and 1:3) in 20mM phosphate buffer of pH 7.0. 
 
 
 
